Partner Spotlight | SIGAL SMS
Chapel Hill, NC (June 23, 2021) – Devana Solutions, LLC is pleased to announce their newest client partnership with SIGAL Site Management and Support (SIGAL SMS). Founded in 2014, SIGAL SMS began a mission to support traditional private practices in their clinical research execution strategies throughout Germany. Today, the SIGAL SMS network connects over 25 sites across Germany, with an average experience of 55 multi-therapeutic studies and 21 years per site.
Realizing the challenges investigators and study teams face, SIGAL SMS offers extensive knowledge to help sites execute studies at the highest level. They offer complete project management support from study start-up to close-out, acting as a liaison between sites, sponsors and CROs. With their modernized approach, SIGAL SMS provides sponsors and CROs the confidence that studies are conducted in a quality and timely manner.
With a goal to standardize their modern approach in clinical trial conduct, SIGAL SMS needed a platform to help fill the technological gaps in their site and study oversight. Now, by leveraging the Devana IGNITE platform, SIGAL SMS has the ability to automate and centrally manage the processes at each site location to ensure that their studies are successful. With a high-level view into their organizational performance via IGNITE’s robust analytics dashboards, SIGAL SMS can assist sponsors and CROs with accurate site selection. From a single source, sponsors and CROs can obtain a group of professionally set up and qualified sites, with proof of their extensive experience in conducting studies and a high patient potential.
“The clinical trials industry has always been globally focused on advancing therapies to improve the human condition. The recent addition of SIGAL SMS, Germany’s leading research site management organization, onto the Devana Solutions’ platform is a testament to the global reach of the industry and our data analytics and workflow automation technology,” said Barry Lake, CEO & Co-Founder, Devana Solutions, LLC.
SIGAL SMS continues their mission to expand its investigative footprint throughout Germany and set a standard in clinical research at an international level. Devana Solutions is proud to support the SIGAL SMS team and their sites to efficiently carry out studies and advance medicine globally.
ABOUT SIGAL SMS:
SIGAL SMS (SIGAL Site Management & Support) is a Site Management Organization (SMO), which specializes in supporting the development, establishment and optimization of established physicians and outpatient practices nationwide in Germany, on their way to become a professional study site.
With their extensive experience in the field of clinical drug research, they know about the problems and difficulties faced by investigators and study teams as well as contractors – sponsors and CROs – every day in clinical trials. Based on this, they developed a concept and founded SIGAL SMS in 2014 to master these challenges as a reliable and competent partner. To learn more visit https://www.sigal-sms.de/en/.
ABOUT DEVANA SOLUTIONS LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.
Partner Spotlight | MOORE Clinical Research
Chapel Hill, NC (May 12, 2021)- Devana Solutions, LLC is pleased to announce their newest client-partnership with MOORE Clinical Research, a privately owned and operated multi-specialty research site specializing in Phase II-IV clinical trials. Founded in 2006, MOORE has completed over 500 clinical trials across their vast and diverse patient population at their three locations in the Tampa Bay area of Florida. Through years of experience and success, MOORE continues to innovate and improve their processes to adapt to the ever-changing clinical trials landscape.
MOORE’s forward-thinking leadership began looking into new technologies to help improve efficiencies around trial identification and management. Already armed with the RealTime CTMS platform, MOORE was introduced to Devana Solutions since the two tech companies have a seamless API-integration. Now, with the two platforms in place, MOORE is able to track trial opportunities from pre-award through trial completion, resulting in an abundance of reportable performance metrics to share with Sponsors and CROs.
“Moore Clinical Research is an excellent addition to our Devana Solutions’ client-partner, hyperCORE International. Moore and the entire hyperCORE super network, which is now over 100 sites worldwide, are able to leverage our Devana IGNITE & PROPEL platforms to rapidly mobilize in study startup and to mine robust analytics and reporting to ensure the organization remains one of the most predictable and reliable performers in the clinical trials industry,” said Barry Lake, CEO, and Co-Founder of Devana Solutions, LLC.
By leveraging Devana’s pioneering platforms, MOORE hopes to continue to increase their trial volume by expanding their capabilities into more therapeutic areas. After implementing Devana’s IGNITE platform, MOORE has already doubled their total number of feasibility requests and site qualification visits per month. With this increase, MOORE is well on their way to exceeding the goals set in place for 2021. Devana Solutions is looking forward to being a part of MOORE’s continued growth and success!
ABOUT MOORE CLINICAL RESEARCH
Founded in 2006, MOORE Clinical Research, Inc. is a privately owned and operated clinical trial site specializing and experienced in conducting multi-specialty Phase II-IV clinical trials. We have three site locations across the Tampa Bay area, each covering a large and diverse patient base.
Our staff comes with over 100 years of research experience collectively and has consistently demonstrated a record of quality, integrity, and reliability. Since our inception in 2006, our demonstrated track record puts MOORE Clinical Research at the forefront when it comes to integrity and accuracy in clinical research.
To learn more, please visit https://mooreclinicalresearch.com.
ABOUT DEVANA SOLUTIONS LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for sharing performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more, visit https://devanasolutions.com.
Partner Spotlight | Icon Group
CHAPEL HILL, NC (April 14, 2021) — Devana Solutions, LLC is pleased to announce their newest client-partnership with the Icon Group, Australia’s largest dedicated provider of private cancer care. Icon Group has an extensive clinical trials program, and through its continuing growth, Devana’s IGNITE platform will help support their ongoing success.
Icon Research provides patients and clinicians with access to new and emerging advances in cancer treatment, conducting trials in hematology, medical oncology, and radiation oncology across a wide range of cancer types. Within the private setting, Icon Research has an unparalleled track record of participating in national and international clinical trials, including Phase I to IV, pharmaceutical industry-sponsored, and collaborative studies undertaken in partnership with various universities and collaborative groups.
Alongside the extensive clinical trials program, Icon Research conducts in-house clinical studies across clinical hematology, medical oncology, radiation oncology, nursing, pharmacy, and medical physics. This research provides professional development opportunities to Icon investigators and the wider Icon team and continues to pave the way for new advances in quality cancer care.
In 2020, Icon Research initiated an internal restructure to better support their expected growth, which led them to Devana Solutions. Devana’s IGNITE platform will help increase the ease and efficiency in research feasibility and start-up processes. This platform allows pre-CTMS data collection to occur, standardized reporting, pipeline tracking, and automated workflows, all of which reduce the time it takes for a trial to begin. IGNITE integrates with Icon’s preferred CTMS, RealTime, allowing a seamless transfer of a trial from feasibility and start-up assessment into an active and financially tracked clinical trial. This integration removes the need for duplicate data entry and prevents the loss of important assessment data previously collected.
Devana Solutions supports some of the leading cancer research organizations worldwide, and the Icon Group is no exception. Their tireless dedication to combatting such an invasive and devastating disease is evident in all they do. Devana is honored to help support their efforts in advancing cancer therapies through their innovative and intuitive platforms.
ABOUT ICON GROUP:
Icon Group is Australia’s largest dedicated private provider of cancer care with a growing reach into Asia and New Zealand. The Group is built on a strong but simple vision to deliver the best care possible to as many people as possible, as close to home as possible.
Icon Group’s integrated, end-to-end service model leverages the strengths of a diverse, multi-disciplinary team to achieve this mission. Their businesses encompass all aspects of quality cancer care, including treatment delivery, pharmacy, and chemotherapy compounding. To learn more, visit https://icongroup.global.
ABOUT DEVANA SOLUTIONS LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more, visit https://devanasolutions.com.
Partner Spotlight | Indiana Clinical Trials Center
CHAPEL HILL, NC (February 19, 2021) — Devana Solutions, LLC is proud to announce their newest client-partnership with Indiana Clinical Trials Center (ICTC). The collaboration of Devana’s IGNITE platform and the highly experienced independent research site will allow ICTC to effectively expand their investigative footprint across a growing number of Dermatology practices.
The Indiana Clinical Trials Center was founded in 2005 by Dr. Scott Guenthner, who has conducted over 180 Phase I-IV Dermatology studies. The organization is continuing to grow and their parent company, Summit Dermatology, plans to open more sites in the Midwest over the next few years. The Indiana Clinical Trials Center’s Plainfield location will remain the central core for all new clinical trials.
During this exciting growth period, ICTC’s use of the Devana IGNITE platform will be a vehicle to efficiently manage their trial pipeline and startup for their current and future site locations. ICTC’s central coordinating team will have real-time transparency into each site’s trial activities and performance metrics, with the ability to share accurate data with Sponsors and CROs, helping to boost their predictability and reliability. “In order to stay on target with their growth strategy, ICTC needs to grow Sponsor and CRO confidence in their ability to not only meet enrollment goals, but to rapidly get a trial up and running,” said Emily Wike, Devana’s Director of Strategic Partnerships. “Devana’s robust metrics capture and reporting will be the source of truth for ICTC and will be extremely valuable to their Sponsor and CRO partners.”
ICTC, equipped with forward-thinking leadership, a highly experienced clinical team and now, Devana’s IGNITE platform, will help to catapult them to the next level. There is no doubt that ICTC is on the path to much success and Devana Solutions is delighted to be along their side for this journey.
ABOUT INDIANA CLINICAL TRIALS CENTER:
The Indiana Clinical Trials Center (ICTC) is a comprehensive and highly experienced clinical research site focusing primarily on Phase I – IV dermatologic clinical trials. ICTC is a successful extension of The Dermatology Center of Indiana (DCI) located in Plainfield, Indiana. To learn more visit https://dermindy.com/ictc-2.
ABOUT DEVANA SOLUTIONS LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.
Partner Spotlight | Optimed Research
CHAPEL HILL, NC (February 18, 2021) — Devana Solutions, LLC is pleased to announce their newest client-partnership with Optimed Research, a well-established Integrated Research Organization (IRO) with over 25 years’ experience running clinical trials. Optimed Research’s main site in Columbus, Ohio, is the central hub where they run over thirty trials under the direction of Owner and Founder Dr. Donald McNeil.
Through the Integrated Research Organization model, Optimed Research partners with independent sites in their network. With a comprehensive Clinical Research Coordinator (CRC) training program, Optimed can take a CRC with little to no experience to running a trial independently. Optimed oversees business development, regulatory, data management, and financial support for each of the independent sites, allowing the Investigator and clinical staff to focus on the trial participants and meeting enrollment goals. This process helps to spread clinical trial awareness on a much broader scope.
Due to the vast amount of oversight that Optimed provides to their sites, their VP & Director of Clinical Operations, Annie Schertzer, set out to find a solution to help manage their workload. Annie and other Optimed staff knew it was time to ditch the static spreadsheets to continue with their trending growth. With the addition of the Devana Solutions IGNITE platform, Optimed Research has a more efficient way to manage all of their independent sites within one cloud-based platform, from initial trial lead through trial completion, since Devana integrates with their CTMS, Clinical Research IO. “Optimed Research was already on the cutting-edge of clinical research with their IRO model and CRC training program, but now armed with the IGNITE platform, there are no limitations to what this group can do,” said Devana’s Director of Strategic Partnerships, Emily Wike. “I am excited to see what the future holds for Optimed!”
Devana Solutions is pleased to stand alongside Optimed Research as they continue to grow their network of sites, proving that clinical research can be accessible to all!
About Optimed Research
Optimed Research is proud to be a well-established Integrated Research Organization (IRO) with over 25 years’ experience running clinical trials. Optimed – Columbus houses our team of experts who support all of the sites in our network. Please visit www.optimedresearch.com for more information.
About Devana Solutions
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to the selection of the top-performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.
Announcing Our Clinical Research IO (CRIO) Integration is Complete!
CHAPEL HILL, NC (October 15, 2020) — Devana Solutions, LLC is pleased to announce the successful completion of their seamless integration with leading CTMS platform, Clinical Research IO (CRIO), to continue to help clinical research sites become more efficient by decreasing clinical trial cycle time to speed therapeutic advances to patients.
Devana Solutions’ novel IGNITE platform has added immense value to leading research organizations by providing a platform that streamlines and automates workflows, captures key timing metrics, and provides robust reporting and dashboarding capabilities during study startup and screening and enrollment. To continue to support these organizations, Devana has partnered with CRIO, sharing the same value and mission, to simplify and make the entire clinical trial process more efficient.
“Whenever Devana looks to launch a strategic partnership with another technology provider to benefit our customers, we look for a firm that is innovative and has deep roots in the research site sector,” stated Barry Lake, Devana Solutions’ CEO, “Clinical Research IO, under Raymond’s leadership, certainly checks both of these boxes.”
“At Clinical Research IO, we distinguish ourselves with a product that seamlessly addresses the challenges in clinical trials. Our collaboration with another industry trail blazer, Devana, is a partnership that will further increase clinical trial efficiency,” said CRIO’s Co-Founder, Raymond Nomizu. “A data driven approach enhances every site’s ability to make critical decisions and taking advantage of our technology allows sites to gather and analyze more data than ever before. We look forward to implementing this partnership with our growing list of mutual clients.”
With the integration now complete, the two companies’ mutual client-partners will benefit from an end-to-end business intelligence solution, providing transparency into clinical trial performance metrics for analysis and decision-making. The combined efficiencies that Devana IGNITE and CRIO provide will speed up the clinical trial process, help leadership to make more informed decisions and ultimately, advance therapies to patients faster and at a lower cost.
ABOUT DEVANA SOLUTIONS, LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce clinical trial cycle time and costs to speed the delivery of new therapies to patients. Devana Solutions offers three platforms, IGNITE, PROPEL and IQ for sponsors and CROs, to provide historical and real-time data capture, aggregation and display to drug development stakeholders. For more information call (877) DEVANA-2 or visit www.devanasolutions.com.
ABOUT CLINCIAL RESEARCH IO:
Clinical Research IO is the leading eSource solution for clinical research sites. Since its launch in September 2016, over 600 research sites have adopted the system. For more information, visit www.clinicalresearch.io.
Announcing Enhanced Integration with RealTime CTMS
CHAPEL HILL, NC (October 7, 2020)- Devana Solutions, LLC is pleased to announce that the API-integration of Devana IGNITE with RealTime CTMS has been enhanced in support of both companies’ mutual customers. Devana IGNITE provides clinical research organizations is the leading cloud platform for pipeline administration, pre-clinical workflow automation and metrics capture and analytics. Devana IGNITE’s functionality is complementary to Real-Time CTMS, a leading provider of workflow automation including patient visit scheduling and related billing during the clinical phase of research studies.
In 2018, Rick Greenfield, CEO of Real-Time and Barry Lake, CEO of Devana Solutions, met at SCRS Site Solutions Summit to explore an integration of their solutions at the behest of mutual customers. “In our earliest days, many of the CTMS makers were skeptical of our intent behind developing Devana IGNITE” Lake explained, “we felt enough good CTMS solutions existed but platforms like Devana to facilitate study startup collaboration across functional groups and the capture and analysis of site performance metrics simply didn’t exist. I really credit Rick for being the first major CTMS maker to embrace an API-connection to reduce duplicate data entry and allow our mutual Real-Time and Devana customers to benefit from a seamless exchange of data from the system where it is best-captured.”
The backdrop driving this latest enhancement to the Real-Time CTMS – Devana IGNITE enhanced connectivity is the clinical trials industry at the site level continuing to consolidate. With research organizations growing and requiring more support from their trusted technology vendors, Devana Solutions and RealTime CTMS had their engineers improve their existing API-integration to function with Real-Time’s recently launched enterprise version supporting integrated site networks. The enhanced integration now expands across both companies’ entire product suite and is available to mutual customers and prospects of Real-Time and Devana Solutions. Both companies’ continued innovation will allow the clinical trials industry to more efficiently deliver advance therapies to patients.
Learn more about the Devana Solutions & RealTime CTMS integration here: https://devanasolutions.com/real-time/
About Devana Solutions, LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.
Partner Spotlight | Rainier Clinical Research Center
CHAPEL HILL, NC (SEPTEMBER 24, 2020)-Devana Solutions, LLC (Devana) is delighted to announce their newest client-partnership with the esteemed Rainier Clinical Research Center (Rainier), located about 15 minutes from downtown Seattle, Washington. The two companies connected when Rainier, a rapidly growing research organization, set out on a journey to find a technology that was able to provide the functionality needed to meet their metrics-focused needs. Once they were introduced to Devana, the journey was complete; they are now armed with the clinical research industry’s leading cloud-based technology to help them forge onward with their growth.
Rainier was founded in 1991 and began conducting research primarily in diabetes. In fact, Rainier has been involved in clinical research relating to all the major classes of diabetes drugs and devices over the past 30 years; quite a remarkable feat! Today, Rainier has expanded their therapeutic expertise beyond diabetes to a multi-therapeutic approach, including obesity, women’s health, and dermatology. With this therapeutic expansion, the need to increase their physical space arose, which brought them to the decision to recently expand into a 15,000 square foot facility, equipped with 11 overnight beds, a study participant recreation lounge, food prep kitchen and even an on-site gym for exercise testing. This new setup allows Rainier to continue their expansion into new therapeutic areas, while providing a comfortable setting for their patients.
Aside from needing a larger facility, Rainier also recognized the need for improved technology. They spent about six months using a very common CRM to manage their trial pipeline and startup activities but quickly realized they needed something better. Eric Hayashi, CEO of Rainier, said, “We became bogged down trying to customize our CRM to meet our needs, which was taking time away from our core competencies in executing clinical trials.” Hayashi, a veteran of four clinical outsourcing startups including LabConnect and Radiant Research over the past 29-years, knew that Rainier needed a technology already customized to meet the clinical research industry’s standards, as well as provide real-time transparency into study startup and performance metrics. Hayashi was very selective during his technology search and when he came across Devana, he knew he had found the best option for his metrics-focused research organization. “We were very thorough in our tech selection process and chose Devana because of the vast metrics they [Devana] provided, as well as their robust reporting and dashboarding capabilities,” said Hayashi.
Although 2020 may have been a tough year thus far, Rainier has not let it discourage them. They are more prepared than ever to take on any challenges that come their way and continue to focus on the most important part of research, the participants. Devana is humbled to partner with the forward-thinking minds at Rainier and look forward to a very successful collaboration.
About Rainier Clinical Research Center:
Rainier Clinical Research Center (RCRC), among the largest and most experienced dedicated clinical trial research sites in the country, has conducted more than 700 multi-specialty Phase I-IV medical device and biopharma clinical trials since 1991. To learn more visit https://rainier-research.com.
About Devana Solutions, LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.
Partner Spotlight | Accel Research Sites
Accel Clinical Services acquires Meridien Research site network, selected as location for Moderna COVID-19 vaccine trial.
CHAPEL HILL, NC (July 29, 2020) — Devana Solutions, LLC (Devana) is celebrating their partner-client’s, Accel Clinical Services (parent company to Accel Research Sites), recent acquisition of AMPLIFY’s esteemed Meridien Research site network, NeuroStudies destination research unit, and the InSearch site business development network. Equally celebratory, Accel Research Sites was also chosen as the only Central Florida location to conduct Moderna’s COVE Phase 3 Study in efforts to develop the first COVID-19 vaccine.
Accel, now armed with a team of over 100 researchers, specializing in multi-phase and multi-therapeutic research, is proof that forward-thinking and innovation is the key to success. It was that same forward-thinking that brought them to their decision to partner with Devana, utilizing Devana’s technology’s time-saving automation and powerful data to make their processes more efficient, better therapeutically align them with Sponsors and CROs, and ultimately land more of the right trial opportunities, some being very timely in the COVID-19 era.
“With our recent acquisition, we were able to more than double our size, adding jobs here in Florida and throughout the Southeast and expanding our trial footprint. We are very excited to serve as a site for several COVID-19 trials and have begun enrolling the first of thousands of participants in the Orlando, Florida area. This is a critical time in our industry and our world, and we are proud to be part of developing a vaccine,” said Matt Maxwell, CEO of Accel Research Sites.
Now, more than ever, clinical research organizations need a tool to strengthen their ability to manage the clinical trial process anywhere, anytime and at an efficient pace. Adaptability is what fuels growth in this industry. Devana continues to innovate to meet the needs of this everchanging industry and support research organizations, like Accel, that continue to move the needle and pave the way forward.
“Supporting high growth, tech-enabled research organizations is what Devana Solutions does best,” said Barry Lake, CEO, Devana Solutions, “Accel Research Sites under Matt’s leadership epitomizes high growth and tech-enabled.”
Devana’s support of Accel, especially as they help to develop a potential vaccine against COVID-19, brings their mission to life. The driving force behind this dynamic and disruptive tech company is knowing that their continuous innovations and enduring partnerships will, ultimately, help save lives. That is their motivation.
About Accel Clinical Services
Accel Clinical Services is a portfolio of companies dedicated to supporting independent physicians and their patients in the delivery of high-quality medical care. It serves as the parent company to subsidiaries built to align services around the needs of its customers: Accel Research Sites, Accel Trial Connections Network, Accel Patient Communities, Accel Provider Communities, and Accel Research Management.
About Accel Research Sites
Accel Research Sites is a multi-therapeutic network of clinical research sites dedicated to the expert delivery of treatment options to patients and providers. They partner with the most innovative and significant pharmaceutical, biotechnology, and medical device companies worldwide to advance healthcare and wellness in the communities they serve.
About Devana Solutions, LLC:
Devana Solutions®, LLC is a cloud SaaS provider driven by a core belief that data transparency through technology is critical to selection of the top performing research sites to align with pharmaceutical Sponsors and CROs to reduce drug development costs and cure disease.
Devana Solutions® flagship platform, Devana IGNITE, allows integrated site networks and research organizations to standardize workflows, particularly in study startup, across site functions while allowing for the capture and display of performance metrics for dashboarding and analytics beyond site CTMS. Devana PROPEL extends performance data transparency across Academic Research Institutions or an expanded network of owned and affiliated investigative sites. Devana IQ allows for the sharing of performance data and documents in real-time between investigative site and Sponsor or CRO stakeholders. To learn more visit https://devanasolutions.com.